EGFR and non-small cell lung carcinoma: The number of EpCAM(+)/EGFR(+)/CK(+)/CD45(−) lung CTCs showed a weak negative correlation with clinical stages in patients with NSCLC (rs = − 0.258, P = 0.015; Table 2).